Company: CERO
Filing Date: 2025-05-27
Form Type: POS AM
Source: 0001213900-25-047469
Chunk: 8

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-05-27
Form: POS AM
Chunk 8
---
 Warrants, the Series A Warrants and the Series C Warrants. “ Conversion Warrants” refer to the warrants initially issued by CERo Therapeutics, Inc. and converted into warrants to purchase Common Stock in connection with the Business Combination. “ Convertible Bridge Notes” refer to the senior secured convertible notes issued by Legacy CERo to certain Legacy CERo Stockholders, which automatically converted into shares of Common Stock upon Closing. “ Danforth” refers to Danforth Advisors, LLC. “ DGCL” refers to the Delaware General Corporation Law, as may be amended from time to time. “ dollars” or “ $” refers to U.S. dollars. iv “Earnout Shares” refer to the Primary Earnout Shares, the Secondary Earnout Shares and the Tertiary Earnout Shares, collectively. “ Exchange Act” refers to the Securities Exchange Act of 1934, as amended. “ FDA” refers to the U.S. Food and Drug Administration, or any successor agency thereto. “ February 2024 Keystone Registration Rights Agreement” refers to the Registration Rights Agreement, dated as of February 14, 2024, by and between CERo and Keystone. “ February 2024 Keystone Purchase Agreement” refers to the Common Stock Purchase Agreement, dated as of February 14, 2024, by and between CERo and Keystone. “ February 2025 Common Warrants” refer to the warrants to purchase shares of Common Stock, at a current exercise price of $1.96 per share, issued by the Company in a public offering on February 7, 2025. “ February 2025 Pre-Funded Warrants” refer to the warrants to purchase shares of Common Stock, at an exercise price of $0.0001 per Share, issued in a public offering on February 7, 2025. “ Fee Modification Agreements” refers to the fee modification agreements between PBAX and certain third-party vendors and service providers, pursuant to which such vendors received shares of Common Stock in lieu of certain payments due to such vendors prior to Closing. “ First PIPE Financing” refers to the private placement pursuant to which we issued and sold, and the PIPE Investors purchased, shares of Series A Preferred Stock, the Series A Warrants and Preferred Warrants, on the terms and conditions set forth in the First Securities Purchase Agreement. “ First PIPE Registration Rights Agreement” refers to the Registration Rights Agreement, dated as of February 14, 2024, by and between CERo and certain